Repro India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 26, 2025, 11:17 am

Competitors of Repro India Ltd

All Competitor Stocks of Repro India Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:57 am

Below is a detailed analysis of the quarterly data for Repro India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 123.06 Cr.. The value appears to be declining and may need further review. It has decreased from 125.94 Cr. (Dec 2024) to 123.06 Cr., marking a decrease of 2.88 Cr..
• For Expenses, as of Mar 2025, the value is 114.65 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 115.57 Cr. (Dec 2024) to 114.65 Cr., marking a decrease of 0.92 Cr..
• For Operating Profit, as of Mar 2025, the value is 8.41 Cr.. The value appears to be declining and may need further review. It has decreased from 10.37 Cr. (Dec 2024) to 8.41 Cr., marking a decrease of 1.96 Cr..
• For OPM %, as of Mar 2025, the value is 6.83%. The value appears to be declining and may need further review. It has decreased from 8.23% (Dec 2024) to 6.83%, marking a decrease of 1.40%.
• For Other Income, as of Mar 2025, the value is 3.94 Cr.. The value appears strong and on an upward trend. It has increased from 0.47 Cr. (Dec 2024) to 3.94 Cr., marking an increase of 3.47 Cr..
• For Interest, as of Mar 2025, the value is 2.22 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.05 Cr. (Dec 2024) to 2.22 Cr., marking an increase of 0.17 Cr..
• For Depreciation, as of Mar 2025, the value is 8.53 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.60 Cr. (Dec 2024) to 8.53 Cr., marking an increase of 0.93 Cr..
• For Profit before tax, as of Mar 2025, the value is 1.60 Cr.. The value appears strong and on an upward trend. It has increased from 1.19 Cr. (Dec 2024) to 1.60 Cr., marking an increase of 0.41 Cr..
• For Tax %, as of Mar 2025, the value is 29.38%. The value appears to be increasing, which may not be favorable. It has increased from 1.68% (Dec 2024) to 29.38%, marking an increase of 27.70%.
• For Net Profit, as of Mar 2025, the value is 1.13 Cr.. The value appears to be declining and may need further review. It has decreased from 1.17 Cr. (Dec 2024) to 1.13 Cr., marking a decrease of 0.04 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.79. The value appears to be declining and may need further review. It has decreased from 0.82 (Dec 2024) to 0.79, marking a decrease of 0.03.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:18 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:27 am

Below is a detailed analysis of the balance sheet data for Repro India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 368.00 Cr.. The value appears to be declining and may need further review. It has decreased from 373.00 Cr. (Mar 2024) to 368.00 Cr., marking a decrease of 5.00 Cr..
• For Borrowings, as of Mar 2025, the value is 99.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 49.00 Cr. (Mar 2024) to 99.00 Cr., marking an increase of 50.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 66.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 66.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 547.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 502.00 Cr. (Mar 2024) to 547.00 Cr., marking an increase of 45.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 319.00 Cr.. The value appears strong and on an upward trend. It has increased from 229.00 Cr. (Mar 2024) to 319.00 Cr., marking an increase of 90.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 46.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 221.00 Cr.. The value appears to be declining and may need further review. It has decreased from 223.00 Cr. (Mar 2024) to 221.00 Cr., marking a decrease of 2.00 Cr..
• For Total Assets, as of Mar 2025, the value is 547.00 Cr.. The value appears strong and on an upward trend. It has increased from 502.00 Cr. (Mar 2024) to 547.00 Cr., marking an increase of 45.00 Cr..

Notably, the Reserves (368.00 Cr.) exceed the Borrowings (99.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Repro India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 5. It has decreased from 8.77 (Mar 24) to -1.44, marking a decrease of 10.21.
• For Diluted EPS (Rs.), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 5. It has decreased from 8.66 (Mar 24) to -1.44, marking a decrease of 10.10.
• For Cash EPS (Rs.), as of Mar 25, the value is 20.44. This value is within the healthy range. It has decreased from 29.21 (Mar 24) to 20.44, marking a decrease of 8.77.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 266.90. It has decreased from 270.89 (Mar 24) to 266.90, marking a decrease of 3.99.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 266.90. It has decreased from 270.89 (Mar 24) to 266.90, marking a decrease of 3.99.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 325.38. It has decreased from 335.29 (Mar 24) to 325.38, marking a decrease of 9.91.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 26.72. This value is within the healthy range. It has decreased from 37.67 (Mar 24) to 26.72, marking a decrease of 10.95.
• For PBIT / Share (Rs.), as of Mar 25, the value is 4.85. This value is within the healthy range. It has decreased from 16.92 (Mar 24) to 4.85, marking a decrease of 12.07.
• For PBT / Share (Rs.), as of Mar 25, the value is -1.06. This value is below the healthy minimum of 0. It has decreased from 10.12 (Mar 24) to -1.06, marking a decrease of 11.18.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 2. It has decreased from 8.46 (Mar 24) to -1.44, marking a decrease of 9.90.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 2. It has decreased from 8.46 (Mar 24) to -1.44, marking a decrease of 9.90.
• For PBDIT Margin (%), as of Mar 25, the value is 8.21. This value is below the healthy minimum of 10. It has decreased from 11.23 (Mar 24) to 8.21, marking a decrease of 3.02.
• For PBIT Margin (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 10. It has decreased from 5.04 (Mar 24) to 1.48, marking a decrease of 3.56.
• For PBT Margin (%), as of Mar 25, the value is -0.32. This value is below the healthy minimum of 10. It has decreased from 3.01 (Mar 24) to -0.32, marking a decrease of 3.33.
• For Net Profit Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 5. It has decreased from 2.52 (Mar 24) to -0.44, marking a decrease of 2.96.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 8. It has decreased from 2.52 (Mar 24) to -0.44, marking a decrease of 2.96.
• For Return on Networth / Equity (%), as of Mar 25, the value is -0.53. This value is below the healthy minimum of 15. It has decreased from 3.12 (Mar 24) to -0.53, marking a decrease of 3.65.
• For Return on Capital Employeed (%), as of Mar 25, the value is 1.62. This value is below the healthy minimum of 10. It has decreased from 5.94 (Mar 24) to 1.62, marking a decrease of 4.32.
• For Return On Assets (%), as of Mar 25, the value is -0.37. This value is below the healthy minimum of 5. It has decreased from 2.41 (Mar 24) to -0.37, marking a decrease of 2.78.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.05, marking an increase of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.18. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.18, marking an increase of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.88. It has decreased from 0.99 (Mar 24) to 0.88, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 1.5. It has decreased from 1.87 (Mar 24) to 1.41, marking a decrease of 0.46.
• For Quick Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has decreased from 1.38 (Mar 24) to 0.97, marking a decrease of 0.41.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.41. This value is within the healthy range. It has increased from 4.96 (Mar 24) to 5.41, marking an increase of 0.45.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.52. This value is within the healthy range. It has decreased from 5.54 (Mar 24) to 4.52, marking a decrease of 1.02.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 3. It has decreased from 2.24 (Mar 24) to 0.75, marking a decrease of 1.49.
• For Enterprise Value (Cr.), as of Mar 25, the value is 631.33. It has decreased from 1,210.32 (Mar 24) to 631.33, marking a decrease of 578.99.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.52 (Mar 24) to 1.35, marking a decrease of 1.17.
• For EV / EBITDA (X), as of Mar 25, the value is 16.50. This value exceeds the healthy maximum of 15. It has decreased from 22.47 (Mar 24) to 16.50, marking a decrease of 5.97.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.22. This value is within the healthy range. It has decreased from 2.48 (Mar 24) to 1.22, marking a decrease of 1.26.
• For Price / BV (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has decreased from 3.07 (Mar 24) to 1.49, marking a decrease of 1.58.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.22. This value is within the healthy range. It has decreased from 2.48 (Mar 24) to 1.22, marking a decrease of 1.26.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness